Net loss was $1.1 M or $0.07 per share Read more…
Product launch and distribution to start immediately Read more…
A net loss of $563 K, or $0.03 per share Read more…
Complaint also requests INJUNCTION on US sales … Read more…
The Q4/12 net loss was $738K or $0.04 per share Read more…
Expanding presence in EU, the Middle East and Latin America Read more…
This transaction is the culmination of previous option agreement to divest the CryoSeal product line. Read more…
Net loss of $1.8M, or $0.11 per share Read more…
Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Read more…
“First-mover” in China for automated processing and storage solutions to address a high growth cord blood market Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.